The Promise of a New Glaucoma Device

With the Food and Drug Administration’s approval in June, 2012 of the iStent Trabecular Micro-Bypass Stent (Glaukos Corporation), glaucoma patients now have access to the first of the microinvasive glaucoma surgery or MIGS devices to reach ...

Full Story →